or Try an Advanced Search...

    ETF Components for OSEA - Harbor International Compounders ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NVO D -4.02 6.25
    FERG B 0.88 6.06
    LIN D -5.20 4.93
    HDB B 1.26 4.74
    TSM C 0.96 4.15

    Represented by ETF Holdings

    Keywords: Aerospace Air Separation Anti Diabetic Drugs Argon Bank Banking Beverage Carbonation Biopharmaceutical Carbon Dioxide Carbon Monoxide Carbonation Cash Management Chemical Chemical Substances Cheque Corporate Advisory Services Corrosion Currency Deposit Products Diabetes
    Industries: Banks - Regional - Asia Biotechnology Industrial Distribution Semiconductors Specialty Chemicals

    Recent News for Harbor International Compounders ETF & its Holdings

    Date Stock Title
    May 2 NVO Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
    May 2 NVO Novo Nordisk slides while Moderna pops: Tale of two pharma stocks
    May 2 NVO Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
    May 2 NVO Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
    May 2 TSM Semiconductor Stocks Pop After Fed Meeting And Strong Numbers From This Chip-Maker
    May 2 NVO Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
    May 2 NVO Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
    May 2 LIN Linde plc (LIN) Q1 2024 Earnings Call Transcript
    May 2 NVO Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation
    May 2 NVO Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript
    May 2 NVO Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat
    May 2 LIN Linde plc 2024 Q1 - Results - Earnings Call Presentation
    May 2 NVO Novo Nordisk Stock Falls After Pricing Pressure Mounts for Wegovy
    May 2 TSM Third Point - Taiwan Semiconductor: The 'Toll Road' For AI Compute
    May 2 NVO Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast
    May 2 NVO GLP-1 drug prices falling at UK pharmacies, clinics: report
    May 2 NVO Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
    May 2 NVO Novo Nordisk says prices dropping for Wegovy, Ozempic: report
    May 2 TSM Is It Time to Buy the Dip on Taiwan Semiconductor?
    May 2 NVO Novo Nordisk Lifts Full-Year Sales Outlook as Obesity, Diabetes Drugs Drive First-Quarter Topline Beat
    Harbor International Compounders ETF is an exchange traded fund launched and managed by Harbor Capital Advisors, Inc. The fund is co-managed by C Worldwide Asset Management FondsmÆGlerselskab A/S. The fund invests in public equity markets of global ex-US region. It invests in stocks of companies operating across diversified sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It invests in stocks of companies that are deemed socially conscious in their business dealings and directly promote environmental responsibility. The fund employs fundamental analysis to create its portfolio. The fund employs proprietary and external research to create its portfolio. Harbor International Compounders ETF is domiciled in the United States.
    Exchange Traded Funds Betashares
    Back to the Main OSEA Page...